Myeloma Center
January 13, 2022
First Myeloma Center Patient Receives Revolutionary New Therapy, Responds Well
Dave Puente of Elk Grove, California, became the first myeloma patient in Arkansas to receive the new chimeric antigen receptor (CAR) T-cell immunotherapy at the University of Arkansas for Medical Sciences (UAMS) Myeloma Center, the only medical facility in Arkansas currently offering the cutting-edge treatment.
November 15, 2021
Pioneering Researcher Returns to UAMS Myeloma Center
John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…
November 10, 2021
UAMS Raises $15 Million Toward NCI Designation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it has raised more than $15 million towards NCI Designation, the halfway point toward its $30 million goal.
September 21, 2021
Be a Part of the Cure Telethon Raises $400,000
The 2nd annual Be a Part of the Cure Telethon to benefit the UAMS Winthrop P. Rockefeller Cancer Institute’s research and treatment programs raised nearly $400,000 despite a second year of pandemic challenges. “Cancer has affected us all, and the Winthrop P. Rockefeller Cancer Institute continues to see patients, provide treatment and take care of…
August 24, 2021
UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8
Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…
August 10, 2021
Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center
LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…
August 9, 2021
UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients
The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.
May 20, 2021
Riney Foundation Gives $1.8 Million to UAMS Myeloma Center in the Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — The Paula and Rodger Riney Foundation announced a gift of $1.8 million to the University of Arkansas for Medical Sciences (UAMS) Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research. “Paula and I are pleased to invest in the UAMS Myeloma Center, which has made great strides…
April 28, 2021
UAMS Cancer Institute’s Volunteers, Paused by the Pandemic, Ready to Return
(UAMS) The UAMS Winthrop P. Rockefeller Cancer Institute’s nearly 70 volunteers may have been out of sight for more than a year thanks to COVID-19, but they have remained close at heart to the Cancer Institute’s staff. For employees of Cancer Institute’s Volunteer Services and Auxiliary department, time and distance has not diminished their appreciation…
April 23, 2021
Twist of fate Leads to Myeloma Diagnosis for Longtime Survivor
A persistent sore spot on his thigh led Bennie Utley of Cabot to ask his family doctor about it in early 2005. “It was about four inches wide and eight or 10 inches long,” Utley, 79, recalled. “He told me I was wearing my belt too tight.” Utley was not satisfied with the diagnosis and…
Previous page Next page